A carregar...

Effects of nintedanib on the microvascular architecture in a lung fibrosis model

Nintedanib, a tyrosine kinase inhibitor approved for the treatment of idiopathic pulmonary fibrosis, has anti-fibrotic, anti-inflammatory, and anti-angiogenic activity. We explored the impact of nintedanib on microvascular architecture in a pulmonary fibrosis model. Lung fibrosis was induced in C57B...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Angiogenesis
Main Authors: Ackermann, Maximilian, Kim, Yong Ook, Wagner, Willi L., Schuppan, Detlef, Valenzuela, Cristian D., Mentzer, Steven J., Kreuz, Sebastian, Stiller, Detlef, Wollin, Lutz, Konerding, Moritz A.
Formato: Artigo
Idioma:Inglês
Publicado em: 2017
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7412751/
https://ncbi.nlm.nih.gov/pubmed/28283856
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10456-017-9543-z
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!